Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Karachaliou, N. (Niki) | - |
| dc.creator | Gonzalez-Cao, M. (María) | - |
| dc.creator | Crespo, G. (Guillermo) | - |
| dc.creator | Drozdowskyj, A. (Ana) | - |
| dc.creator | Aldeguer, E. (Erika) | - |
| dc.creator | Gimenez-Capitan, A. (Ana) | - |
| dc.creator | Teixidó, C. (Cristina) | - |
| dc.creator | Molina-Vila, M.A. (Miguel Angel) | - |
| dc.creator | Viteri, S. (S.) | - |
| dc.creator | Llanos-Gil, M. (Maria) de los | - |
| dc.creator | Martin-Algarra, S. (Salvador) | - |
| dc.creator | Perez-Ruiz, E. (Elisabeth) | - |
| dc.creator | Marquez-Rodas, I. (Iván) | - |
| dc.creator | Rodríguez-Abreu, D. (Delvys) | - |
| dc.creator | Blanco, R. (Remedios) | - |
| dc.creator | Puertolas, T. (Teresa) | - |
| dc.creator | Royo, M.A. (María Ángeles) | - |
| dc.creator | Rosell, R. (Rafael) | - |
| dc.date.accessioned | 2023-03-09T07:59:51Z | - |
| dc.date.available | 2023-03-09T07:59:51Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Karachaliou, N. (Niki); Gonzalez-Cao, M. (María); Crespo, G. (Guillermo); et al. "Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients". Therapeutic advances in medical oncology. 10, 2018, 1 - 23 | es |
| dc.identifier.issn | 1758-8340 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/65643 | - |
| dc.description.abstract | Background: Programmed death-ligand 1 (PD-L1) may be induced by oncogenic signals or can be upregulated via interferon gamma (IFN-y). We have explored whether the expression of IFNG, the gene encoding IFN-y, is associated with clinical response to the immune checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma patients. The role of inflammation-associated transcription factors STAT3, IKBKE, STAT1 and other associated genes has also been examined. | es_ES |
| dc.description.sponsorship | This work was funded by La Caixa Foundation, Barcelona, Spain. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | SAGE Publications | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Immunotherapy | es_ES |
| dc.subject | Interferon-gamma | es_ES |
| dc.subject | PD-1 | es_ES |
| dc.subject | PD-L1 | es_ES |
| dc.subject | Lung cancer | es_ES |
| dc.subject | Melanoma | es_ES |
| dc.title | Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.description.note | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). | es_ES |
| dc.identifier.doi | 10.1177/1758834017749748 | - |
| dadun.citation.endingPage | 23 | es_ES |
| dadun.citation.publicationName | Therapeutic advances in medical oncology | es_ES |
| dadun.citation.startingPage | 1 | es_ES |
| dadun.citation.volume | 10 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
